Altria Group Inc. (MO) Financials Nov 14, 2014, 7:16

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Altria Group Inc. (MO) Financials Nov 14, 2014, 7:16 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Altria Group Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 16.82B 16.89B 17.11B 17.51B 17.66B
Cost of Goods Sold (COGS) incl. D&A 2.87B 2.65B 2.7B 2.85B 2.83B
COGS excluding D&A 2.58B 2.37B 2.45B 2.62B 2.61B
Depreciation & Amortization Expense 291M 276M 253M 225M 212M
Depreciation 271M 256M 233M 205M 192M
Amortization of Intangibles 20M 20M 20M 20M 20M
Gross Income 13.95B 14.24B 14.41B 14.66B 14.84B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.87B 2.72B 2.37B 2.05B 2.05B
Research & Development 177M 144M 128M 136M 153M
Other SG&A 2.7B 2.57B 2.24B 1.91B 1.9B
Other Operating Expense 0 169M 0 0 0
Unusual Expense 5.62B 5.13B 5.99B 6.28B 5.76B
EBIT after Unusual Expense (5.62B) (5.13B) (5.99B) (6.28B) (5.76B)
Non Operating Income/Expense 0 0 14M 52M (16M)
Non-Operating Interest Income 4M 3M 4M 2M 4M
Equity in Affiliates (Pretax) 600M 628M 730M 1.22B 985M
Interest Expense 1.19B 1.14B 1.22B 1.13B 1.05B
Gross Interest Expense 1.19B 1.16B 1.22B 1.13B 1.05B
Interest Capitalized 5M 26M - 0 -
Pretax Income 4.88B 5.72B 5.58B 6.48B 6.94B
Income Tax 1.67B 1.82B 2.19B 2.29B 2.41B
Income Tax - Current Domestic 1.62B 1.69B 2.63B 3.22B 2.49B
Income Tax - Current Foreign 3M 4M 4M 5M 4M
Income Tax - Deferred Domestic 43M 124M (443M) (929M) (86M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) (11M) (15M) (13M) (13M) (12M)
Consolidated Net Income 3.2B 3.89B 3.38B 4.17B 4.52B
Minority Interest Expense 2M 2M 3M 3M 0
Net Income 3.2B 3.89B 3.38B 4.17B 4.52B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 3.2B 3.89B 3.38B 4.17B 4.52B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.2B 3.89B 3.38B 4.17B 4.52B
EPS (Basic) 1.55 1.87 1.64 2.06 2.26
Basic Shares Outstanding 2.07B 2.08B 2.06B 2.02B 2B
EPS (Diluted) 1.54 1.87 1.64 2.06 2.26
Diluted Shares Outstanding 2.07B 2.08B 2.06B 2.02B 2B
EBITDA 11.37B 11.64B 12.3B 12.84B 13B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading